Infantile Neuroaxonal Dystrophy: Case Report and Review of Literature.
Alian FatimaShahd A AbuhijlehAbdul FatahMariam M MohsinSubhranshu Sekhar KarRajani DubeBiji Thomas GeorgeManjunatha Goud Bellary KurubaPublished in: Medicina (Kaunas, Lithuania) (2024)
Infantile neuroaxonal dystrophy (INAD) is a rare neurodegenerative disorder affecting 1:1,000,000 children. It results from pathogenic variants in the PLA2G6 gene located on chromosome 22q13.1. The onset of symptoms usually occurs between 6 and 18 months, causing developmental regression leading to debilitating symptoms such as muscle weakness, dementia, and loss of basic skills. Eventually, it progresses to life-threatening symptoms, including breathing difficulties, which limit the life expectancy to 5-10 years. While potential genetic therapies for treatment are being developed, they are yet to be approved for use, and management remains essentially supportive. This case report is about a nine-year-old Pakistani girl with INAD. She presented with recurrent chest infections, developmental regression, loss of speech, paralysis, hypertension, and eventually breathing difficulties. Brain magnetic resonance imaging and genetic testing confirmed the diagnosis. This case posed diagnostic challenges in view of its overlapping clinical presentation. Through this report, we aim to raise awareness about this condition among practitioners, outline the importance of genetic counseling in susceptible couples, and suggest potential areas of further research.
Keyphrases
- copy number
- magnetic resonance imaging
- genome wide
- case report
- blood pressure
- sleep quality
- early onset
- primary care
- young adults
- mild cognitive impairment
- computed tomography
- dna methylation
- human health
- smoking cessation
- human immunodeficiency virus
- contrast enhanced
- combination therapy
- hearing loss
- medical students